Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols
/ therapeutic use
Bleomycin
/ therapeutic use
Cyclophosphamide
/ therapeutic use
Disease-Free Survival
Doxorubicin
/ therapeutic use
Female
Fluorodeoxyglucose F18
Humans
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse
/ diagnostic imaging
Male
Middle Aged
Multivariate Analysis
Neoplasm Metastasis
Neoplasm Staging
Positron-Emission Tomography
Prednisone
/ therapeutic use
ROC Curve
Risk Assessment
Rituximab
/ therapeutic use
Treatment Outcome
Vincristine
/ therapeutic use
Vindesine
/ therapeutic use
Young Adult
18F-FDG PET/CT
DLBCL
dissemination
lymphoma
metabolic tumor volume
oncology
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
08
04
2019
accepted:
03
06
2019
pubmed:
16
6
2019
medline:
4
8
2020
entrez:
16
6
2019
Statut:
ppublish
Résumé
We assessed the predictive value of new radiomic features characterizing lesion dissemination in baseline
Identifiants
pubmed: 31201248
pii: jnumed.119.229450
doi: 10.2967/jnumed.119.229450
pmc: PMC6954460
doi:
Substances chimiques
R-CHOP protocol
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Bleomycin
11056-06-7
Rituximab
4F4X42SYQ6
Vincristine
5J49Q6B70F
Doxorubicin
80168379AG
Cyclophosphamide
8N3DW7272P
Vindesine
RSA8KO39WH
Prednisone
VB0R961HZT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
40-45Informations de copyright
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Blood. 2017 Oct 19;130(16):1800-1808
pubmed: 28774879
J Pathol. 2015 Feb;235(3):445-55
pubmed: 25231113
Blood. 2014 Feb 6;123(6):837-42
pubmed: 24264230
Clin Cancer Res. 2016 Aug 1;22(15):3801-9
pubmed: 26936916
Oncotarget. 2019 Jan 22;10(7):717-731
pubmed: 30774774
Blood. 2007 Mar 1;109(5):1857-61
pubmed: 17105812
J Clin Oncol. 2007 Feb 10;25(5):579-86
pubmed: 17242396
J Clin Oncol. 2010 Sep 20;28(27):4184-90
pubmed: 20660832
Blood. 2007 Nov 1;110(9):3102-11
pubmed: 17656647
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1209-19
pubmed: 26902371
J Clin Oncol. 2017 Nov 1;35(31):3529-3537
pubmed: 28796588
J Clin Oncol. 2018 Oct 1;36(28):2845-2853
pubmed: 30125215
Theranostics. 2015 Mar 01;5(6):618-30
pubmed: 25825601
Blood. 2017 May 11;129(19):2616-2623
pubmed: 28251914
CA Cancer J Clin. 2016 Nov 12;66(6):443-459
pubmed: 27618563
Blood. 2017 Sep 14;130(11):1315-1326
pubmed: 28701367
Cancer Res. 2018 Aug 15;78(16):4786-4789
pubmed: 29959149
Oncotarget. 2015 Mar 20;6(8):5597-614
pubmed: 25704881
Ann Oncol. 2015 Sep;26 Suppl 5:v116-25
pubmed: 26314773
J Clin Oncol. 2016 Oct 20;34(30):3618-3626
pubmed: 27551111
N Engl J Med. 1993 Sep 30;329(14):987-94
pubmed: 8141877
Eur J Nucl Med Mol Imaging. 2018 May;45(5):680-688
pubmed: 29344718